Senior insider sale
Chief Financial Officer at VIRIDIAN THERAPEUTICS, INC.\DE — senior position signals high conviction
$61.3K
2.03K shares
What this filing means
HARMON SETH plans to sell 2.03K shares of VIRIDIAN THERAPEUTICS, INC.\DE valued at approximately $61.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001959173-26-001925
Officer· Chief Financial Officer
Since Mar 2026
2.03K
Shares to sell
$61.3K
Approx. market value
2.03K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/3/2026
2.03KTotal acquired2.03K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2026 | Restricted Stock Vesting Compensation | 2.03K | — |
| Total | 2.03K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.03K
Market value
$61.3K
3/4/2026
Total
Units
2.03K
Value
$61.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/4/2026 | 2.03K | $61.3K | NASDAQ | Planned |
| Total | 2.03K | $61.3K | ||